← Leaderboards
Shailendra Giri
Henry Ford Health System
$3,996,660
Attributed
$3,996,660
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $750.8K · FY2010–23$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,996,660 · 3
By mechanism
R01$3,585,668 · 2
R21$410,992 · 1
Top collaborators
No co-investigators on record.
Most similar at Henry Ford Health System
Same institution · by research overlap
- Ramandeep Rattan$1,690,360
- Suresh Selvaraj Palaniyandi$1,921,686
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryDisease ProgressionMouse ModelAffectInflammationDesignChronicMetabolicMultiple SclerosisRelapseCytokineMacrophage-Amp-Activated Protein KinaseExperimental Autoimmune Encephalomyelitis5&AposAutoimmune DiseasesMediatingCellsCellular Metabolic ProcessAnti-Inflammatory AgentsBaseBiochemistryExperimental StudyInnovation
Grant awards (12)
Novel Regulation and Targeting of Macrophages Metabolism in Neuroinflammatory Disorders$376,250
R01 · FY2023 · AI · contact PI
Endogenous metabolite restricts GM-CSF signaling pathway in pathogenic macrophages to ameliorate CNS Autoimmunity$329,219
R01 · FY2023 · NS · contact PI
Novel Regulation and Targeting of Macrophages Metabolism in Neuroinflammatory Disorders$389,213
R01 · FY2022 · AI · contact PI
Endogenous metabolite restricts GM-CSF signaling pathway in pathogenic macrophages to ameliorate CNS Autoimmunity$329,219
R01 · FY2022 · NS · contact PI
Novel Regulation and Targeting of Macrophages Metabolism in Neuroinflammatory Disorders$421,610
R01 · FY2021 · AI · contact PI
Endogenous metabolite restricts GM-CSF signaling pathway in pathogenic macrophages to ameliorate CNS Autoimmunity$329,219
R01 · FY2021 · NS · contact PI
Novel Regulation and Targeting of Macrophages Metabolism in Neuroinflammatory Disorders$376,250
R01 · FY2020 · AI · contact PI
Endogenous metabolite restricts GM-CSF signaling pathway in pathogenic macrophages to ameliorate CNS Autoimmunity$329,219
R01 · FY2020 · NS · contact PI
Novel Regulation and Targeting of Macrophages Metabolism in Neuroinflammatory Disorders$376,250
R01 · FY2019 · AI · contact PI
Endogenous metabolite restricts GM-CSF signaling pathway in pathogenic macrophages to ameliorate CNS Autoimmunity$329,219
R01 · FY2019 · NS · contact PI
Therapeutic efficacy of metformin in the disease process of EAE$222,117
R21 · FY2011 · NS · contact PI
Therapeutic efficacy of metformin in the disease process of EAE$188,875
R21 · FY2010 · NS · contact PI